Author Description

This second of two volumes presents the state of the art in somatostatin analogues and bombesin antagonists in neoplastic diseases. It provides a detailed description of mechanisms of action and the present clinical relevance of these new approaches in cancer treatment. Each chapter has been prepared by an expert active in the respective experimental and/or clinical field so that the reader is assured of obtaining the latest information on the topic.